4.3 Article

Validity of self-assessed waist circumference in a multi-ethnic UK population

Journal

DIABETIC MEDICINE
Volume 29, Issue 3, Pages 404-409

Publisher

WILEY-BLACKWELL
DOI: 10.1111/j.1464-5491.2011.03478.x

Keywords

screening; Type 2 diabetes

Funding

  1. Department of Health NIHR
  2. Department of Health, UK
  3. MRC [MC_U106179474] Funding Source: UKRI
  4. Medical Research Council [MC_U106179474] Funding Source: researchfish
  5. National Institute for Health Research [RP-PG-0606-1259] Funding Source: researchfish

Ask authors/readers for more resources

Aims To investigate validity of waist circumference measurements obtained by self-report and self-measurement with non-verbal pictorial instructions among a multi-ethnic population. Methods Five hundred and twenty-six individuals aged 4075 years (91 South Asian, 430 White European and five other), who attended a screening programme for Type 2 diabetes, estimated their waist circumference and measured their waist with a paper tape measure. Participants were also provided with simple pictorial instructions for measurement of waist circumference in their preferred language and remeasured their waist circumference. We calculated 95% limits of agreement with measures undertaken by a healthcare professional unaware of prior measures. Results Mean age was 56.8 years (sd 9.0), mean BMI 30.0 kg/m2 (sd 5.6) and mean waist circumference 98.4 cm (sd 14.1). Seventy-nine per cent had high waist circumference according to International Diabetes Federation criteria. The mean of participants self-reported value was 6.8 cm lower than the healthcare professional measure (sd 8.8; 95% limits of agreement -10.4 to 24.0 cm), with significant differences by sex and ethnicity (South Asian men 7.5 cm, South Asian women 0.1 cm, White European men 7.8 cm, White European women 7.0 cm, P < 0.001). Compared with healthcare professional measures, mean self-measured waist circumference was very similar, both with instructions (0.4 cm higher; sd 5.5 cm; -11.1 to 10.4 cm) and without instructions (0.5 cm lower; sd 5.6; -10.4 to 11.4 cm), but with significant differences by sex and ethnicity (P < 0.001). Conclusions There was systematic underestimation of self-reported waist circumference in this multi-ethnic UK population. The magnitude of underestimation might reduce the performance of risk scores; however, this can be corrected through self-measurement with pictorial instructions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Public, Environmental & Occupational Health

Variations in documentation of atrial fibrillation predicted by population and service level characteristics in primary health care in England

Ash Routen, Sophia Abner, Louis S. Levene, Clare L. L. Gillies, Melanie Davies, Samuel Seidu, G. Andre Ng, Kamlesh Khunti

Summary: This study used published data to describe differences in documented and estimated atrial fibrillation (AF) prevalence in general practices in England, and explored predictors of variations in AF prevalence. The results showed that documented AF prevalence was lower than estimated. Practice and population characteristics were found to be associated with variations in AF documentation.

JOURNAL OF PUBLIC HEALTH (2023)

Article Public, Environmental & Occupational Health

COVID-19 vaccination uptake amongst ethnic minority communities in England: a linked study exploring the drivers of differential vaccination rates

Charlotte Hannah Gaughan, Cameron Razieh, Kamlesh Khunti, Amitava Banerjee, Yogini Chudasama, Melanie J. Davies, Ted Dolby, Clare L. Gillies, Claire Lawson, Evgeny M. Mirkes, Jasper Morgan, Karen Tingay, Francesco Zaccardi, Thomas Yates, Vahe Nafilyan

Summary: Despite high vaccination rates in the UK, certain ethnic minority communities have lower take-up rates. All ethnic groups have lower vaccination rates compared to the white British population, with black communities having the lowest rates.

JOURNAL OF PUBLIC HEALTH (2023)

Article Clinical Neurology

Mortality in a Multiethnic Population Attending a One-Stop TIA Clinic

Meeriam Kadicheeni, Jatinder S. Minhas, Briana Coles, Shazia T. Hussain, Kamlesh Khunti, Thompson G. Robinson, David J. Eveson, Amit K. Mistri

Summary: This study aims to assess the mortality rate of TIA patients in a rapid-access clinic. The results showed that the mortality rate was higher following a CV diagnosis, and it was associated with males, older individuals, white ethnicity, and orthostatic hypotension.

CEREBROVASCULAR DISEASES (2023)

Article Endocrinology & Metabolism

Associations of microvascular complications with all-cause death in patients with diabetes and COVID-19: The CORONADO, ABCD COVID-19 UK national audit and AMERICADO study groups

Samy Hadjadj, Pierre-Jean Saulnier, Yue Ruan, Xu Zhu, Renee Pekmezaris, Michel Marre, Jean Michel Halimi, Matthieu Wargny, Rustam Rea, Pierre Gourdy, Bertrand Cariou, Alyson K. Myers, Kamlesh Khunti

Summary: Microvascular complications are associated with increased risk of death in patients hospitalized for COVID-19.

DIABETES OBESITY & METABOLISM (2023)

Article Endocrinology & Metabolism

Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second-line glucose-lowering therapy: The global DISCOVER study

Bernard H. Charbonnel, Hungta Chen, Javier Cid-Ruzafa, Andrew Cooper, Peter Fenici, Marilia B. Gomes, Gabriela L. Saraiva, Jesus Medina, Antonio Nicolucci, Marina Shestakova, Iichiro Shimomura, Filip Surmont, Fengming Tang, Jiten Vora, Hirotaka Watada, Kamlesh Khunti

Summary: Dual oral therapy was the most common treatment regimen at the start of second-line treatment, and over half of the participants remained on the same treatment during follow-up.

DIABETES OBESITY & METABOLISM (2023)

Article Endocrinology & Metabolism

Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses

Mikhail N. Kosiborod, Meena Bhatta, Melanie Davies, John E. Deanfield, W. Timothy Garvey, Usman Khalid, Robert Kushner, Domenica M. Rubino, Niels Zeuthen, Subodh Verma

Summary: This study evaluated the effects of once-weekly subcutaneous semaglutide 2.4 mg on cardiometabolic risk factors in people with overweight/obesity without diabetes. The results showed that semaglutide can improve waist circumference, blood pressure, blood glucose, and lipid levels, and reduce the use of antihypertensive and lipid-lowering medications. However, these benefits were not maintained after treatment discontinuation.

DIABETES OBESITY & METABOLISM (2023)

Article Medicine, General & Internal

Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update

Sankar D. Navaneethan, Sophia Zoungas, M. Luiza Caramori, Juliana C. N. Chan, Hiddo J. L. Heerspink, Clint Hurst, Adrian Liew, Erin D. Michos, Wasiu A. Olowu, Tami Sadusky, Nikhil Tandon, Katherine R. Tuttle, Christoph Wanner, Katy G. Wilkens, Jonathan C. Craig, David J. Tunnicliffe, Marcello Tonelli, Michael Cheung, Amy Earley, Peter Rossing, Ian H. de Boer, Kamlesh Khunti

Summary: The KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease is an update of the 2020 guideline. The guideline was updated based on reviewing new evidence and using the GRADE approach to assess evidence and develop consensus practice points. The recommendations were updated in the areas of comprehensive care and glucose-lowering therapies, while recommendations in the areas of glycemic monitoring, lifestyle interventions, and management approaches remained unchanged.

ANNALS OF INTERNAL MEDICINE (2023)

Article Medicine, General & Internal

Ethnic differences in COVID-19 mortality in the second and third waves of the pandemic in England during the vaccine rollout: a retrospective, population-based cohort study

Matthew L. Bosworth, Tamanna Ahmed, Tim Larsen, Luke Lorenzi, Jasper Morgan, Raghib Ali, Peter Goldblatt, Nazrul Islam, Kamlesh Khunti, Veena Raleigh, Daniel Ayoubkhani, Neil Bannister, Myer Glickman, Vahe Nafilyan

Summary: Ethnic minority groups in England have been disproportionately affected by the COVID-19 pandemic and have lower vaccination rates. This study examines whether ethnic differences in COVID-19 mortality have persisted since the vaccine rollout and to what extent vaccination rates contribute to excess mortality. The findings suggest that lower vaccination uptake in certain ethnic groups contributes to the disparities in COVID-19 mortality.

BMC MEDICINE (2023)

Article Endocrinology & Metabolism

Age at Diagnosis of Type 2 Diabetes and Depressive Symptoms, Diabetes-Specific Distress, and Self-Compassion

Mary M. Barker, Melanie J. Davies, Francesco Zaccardi, Emer M. Brady, Andrew P. Hall, Joseph J. Henson, Kamlesh Khunti, Amelia Lake, Emma L. Redman, Alex V. Rowlands, Jane Speight, Tom Yates, Jack A. Sargeant, Michelle Hadjiconstantinou

Summary: This study investigated the association between age at diagnosis of type 2 diabetes and depressive symptoms, diabetes-specific distress, and self-compassion. The results showed that younger age at diagnosis was significantly associated with higher levels of depressive symptoms and diabetes-specific distress, and lower levels of self-compassion.

DIABETES CARE (2023)

Article Endocrinology & Metabolism

Inequalities in cancer mortality trends in people with type 2 diabetes: 20 year population-based study in England

Suping Ling, Francesco Zaccardi, Eyad Issa, Melanie J. Davies, Kamlesh Khunti, Karen Brown

Summary: The aim of this study was to examine long-term trends in cancer mortality rates among individuals with type 2 diabetes, based on various demographic and risk factor subgroups. The results showed that while overall mortality rates decreased, cancer mortality rates increased in older individuals with type 2 diabetes, especially for colorectal, pancreatic, liver, and endometrial cancer. This highlights the need for tailored cancer prevention and early detection strategies to address disparities in the older population, individuals of lower socioeconomic status, and smokers.

DIABETOLOGIA (2023)

Review Public, Environmental & Occupational Health

Physical activity and risk of chronic kidney disease: systematic review and meta-analysis of 12 cohort studies involving 1,281,727 participants

Samuel Seidu, Mohammad Abdool, Abdullah Almaqhawi, Thomas J. Wilkinson, Setor K. Kunutsor, Kamlesh Khunti, Tom Yates

Summary: Regular physical activity is associated with a reduced risk of chronic kidney disease (CKD) in the general population, according to a systematic review and meta-analysis of observational cohort studies. However, the quality of the evidence is low.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2023)

Review Health Care Sciences & Services

The Use of Digital Health Interventions for Cardiometabolic Diseases Among South Asian and Black Minority Ethnic Groups: Realist Review

Aumeya Goswami, Lydia Poole, Zareen Thorlu-Bangura, Nushrat Khan, Wasim Hanif, Kamlesh Khunti, Paramjit Gill, Madiha Sajid, Ann Blandford, Fiona Stevenson, Amitava Banerjee, Mel Ramasawmy

Summary: This study investigated the use of digital health interventions (DHIs) for cardiovascular disease and type 2 diabetes among minority ethnic populations. The study found that DHIs are suitable for minority ethnic populations when specific factors are considered, including patients' beliefs, health needs, education and literacy levels, material circumstances, culture, social networks, and supporting healthcare systems.

JOURNAL OF MEDICAL INTERNET RESEARCH (2023)

Article Medicine, General & Internal

Using national electronic health records for pandemic preparedness: validation of a parsimonious model for predicting excess deaths among those with COVID-19-a data-driven retrospective cohort study

Mehrdad A. Mizani, Ashkan Dashtban, Laura Pasea, Alvina G. Lai, Johan Thygesen, Chris Tomlinson, Alex Handy, Jil B. Mamza, Tamsin Morris, Sara Khalid, Francesco Zaccardi, Mary Joan Macleod, Fatemeh Torabi, Dexter Canoy, Ashley Akbari, Colin Berry, Thomas Bolton, John Nolan, Kamlesh Khunti, Spiros Denaxas, Harry Hemingway, Cathie Sudlow, Amitava Banerjee, C. V. D. C. O. V. I. D. U. K. Consortium CVD COVID UK Consortium

Summary: A simple model using national, pre- and post-pandemic electronic health records has been developed to predict excess deaths in the early stages of a pandemic. Despite limited use in emergency preparedness, electronic health records can provide information for pandemic planning and surveillance.

JOURNAL OF THE ROYAL SOCIETY OF MEDICINE (2023)

Article Sport Sciences

Self-reported walking pace: A simple screening tool with lowest risk of all-cause mortality in those that 'walk the talk'

Alex V. Rowlands, Paddy C. Dempsey, Benjamin Maylor, Cameron Razieh, Francesco Zaccardi, Melanie J. Davies, Kamlesh Khunti, Thomas Yates

Summary: This study examined the association between self-reported walking pace and all-cause mortality (ACM), and found that the association persisted across different categories of accelerometer-assessed physical activity status. The results showed that a higher walking pace was associated with higher physical activity levels and lower risk of all-cause mortality. The findings highlight the importance of both self-reported walking pace and accelerometer-assessed physical activity in predicting mortality risk.

JOURNAL OF SPORTS SCIENCES (2023)

Article Biochemistry & Molecular Biology

Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial

Barry A. Borlaug, Dalane W. Kitzman, Melanie J. Davies, Soren Rasmussen, Eric Barros, Javed Butler, Mette Nygaard Einfeldt, G. Kees Hovingh, Daniel Vega Moller, Mark C. Petrie, Sanjiv J. Shah, Subodh Verma, Walter Abhayaratna, Fozia Z. Ahmed, Vijay Chopra, Justin Ezekowitz, Michael Fu, Hiroshi Ito, Malgorzata Lelonek, Vojtech Melenovsky, Julio Nunez, Eduardo Perna, Morten Schou, Michele Senni, Peter van der Meer, Dirk Von Lewinski, Dennis Wolf, Mikhail N. Kosiborod

Summary: In the STEP-HFpEF trial, semaglutide demonstrated positive treatment effects on symptoms, physical limitations, exercise function, and body weight in patients with the obesity phenotype of heart failure with preserved ejection fraction (HFpEF). The results showed that semaglutide consistently improved outcomes across different obesity categories and the magnitude of benefit was directly related to the extent of weight loss.

NATURE MEDICINE (2023)

No Data Available